Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Retosiban

Generic Name: Retosiban

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₃₄N_₄O_₅

CAS Number: 820957-38-8

Unique Ingredient Identifier: GIE06H28OX

Overview

Retosiban has been used in trials studying the treatment of Premature Labor and Obstetric Labour, Premature.

Background

Retosiban has been used in trials studying the treatment of Premature Labor and Obstetric Labour, Premature.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women

Phase 1

Completed

Posted: 2015/03/03

Sponsor:GlaxoSmithKline

ID:NCT02377414

A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor

Phase 3

Terminated

Posted: 2015/03/03

Sponsor:GlaxoSmithKline

ID:NCT02377466

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

Phase 3

Completed

Posted: 2014/11/17

Sponsor:GlaxoSmithKline

ID:NCT02292784

A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour

Phase 3

Terminated

Posted: 2014/11/17

Sponsor:GlaxoSmithKline

ID:NCT02292771

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)

Phase 1

Completed

Posted: 2013/06/04

Sponsor:GlaxoSmithKline

ID:NCT01867996

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy